Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moreira

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Nature Reviews. Immunology|September 28, 2024
Induced pluripotent stem cell-derived macrophages as a platform for modelling human diseaseSatish Kumar Tiwari, Wei Jie Wong, Marco Moreira, et al.
Cancers|January 13, 2021
Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC)Audrey Simonaggio, Nicolas Epaillard, Cédric Pobel, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Resistance to cancer immunotherapy in metastatic renal cell carcinomaMarco Moreira, Cedric Pobel, Nicolas Epaillard, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|February 16, 2024
Electrical properties of strained off-stoichiometric Cu-Cr-O delafossite thin filmsMarco Moreira, Jonathan Crêpellière, Jérôme Polesel-Maris, et al.
Bulletin Du Cancer|July 5, 2020
[Impact of molecular signatures on the choice of systemic treatment for metastatic kidney cancer]Audrey Simonaggio, Nicolas Epaillard, Reza Elaidi, et al.
Nanomaterials (Basel, Switzerland)|September 11, 2019
Tailoring IGZO Composition for Enhanced Fully Solution-Based Thin Film TransistorsMarco Moreira, Emanuel Carlos, Carlos Dias, et al.
Seminars in Immunology|November 29, 2020
Tertiary Lymphoid Structures and B cells: Clinical impact and therapeutic modulation in cancerCatherine Sautès-Fridman, Johanna Verneau, Cheng-Ming Sun, et al.
Bulletin Du Cancer|July 5, 2020
BIONIKK: A phase 2 biomarker driven trial with nivolumab and ipilimumab or VEGFR tyrosine kinase inhibitor (TKI) in naïve metastatic kidney cancerNicolas Epaillard, Audrey Simonaggio, Reza Elaidi, et al.
Drug Delivery and Translational Research|December 7, 2023
Multicellular tumor spheroid model to study the multifaceted role of tumor-associated macrophages in PDACNadège Bidan, Garett Dunsmore, Martina Ugrinic, et al.
The Oncologist|March 12, 2022
Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint InhibitorsJustine Gantzer, Guillaume Davidson, Bujamin Vokshi, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Nature Reviews. Immunology|September 28, 2024
Induced pluripotent stem cell-derived macrophages as a platform for modelling human diseaseSatish Kumar Tiwari, Wei Jie Wong, Marco Moreira, et al.
Cancers|January 13, 2021
Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC)Audrey Simonaggio, Nicolas Epaillard, Cédric Pobel, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Resistance to cancer immunotherapy in metastatic renal cell carcinomaMarco Moreira, Cedric Pobel, Nicolas Epaillard, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|February 16, 2024
Electrical properties of strained off-stoichiometric Cu-Cr-O delafossite thin filmsMarco Moreira, Jonathan Crêpellière, Jérôme Polesel-Maris, et al.
Bulletin Du Cancer|July 5, 2020
[Impact of molecular signatures on the choice of systemic treatment for metastatic kidney cancer]Audrey Simonaggio, Nicolas Epaillard, Reza Elaidi, et al.
Nanomaterials (Basel, Switzerland)|September 11, 2019
Tailoring IGZO Composition for Enhanced Fully Solution-Based Thin Film TransistorsMarco Moreira, Emanuel Carlos, Carlos Dias, et al.
Seminars in Immunology|November 29, 2020
Tertiary Lymphoid Structures and B cells: Clinical impact and therapeutic modulation in cancerCatherine Sautès-Fridman, Johanna Verneau, Cheng-Ming Sun, et al.
Bulletin Du Cancer|July 5, 2020
BIONIKK: A phase 2 biomarker driven trial with nivolumab and ipilimumab or VEGFR tyrosine kinase inhibitor (TKI) in naïve metastatic kidney cancerNicolas Epaillard, Audrey Simonaggio, Reza Elaidi, et al.
Drug Delivery and Translational Research|December 7, 2023
Multicellular tumor spheroid model to study the multifaceted role of tumor-associated macrophages in PDACNadège Bidan, Garett Dunsmore, Martina Ugrinic, et al.
The Oncologist|March 12, 2022
Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint InhibitorsJustine Gantzer, Guillaume Davidson, Bujamin Vokshi, et al.
Pageof 2